Summary
Benzodiazepines are among the most frequently prescribed drugs worldwide. This popularity is based not only on their efficacy but also on their remarkable safety. Pure benzodiazepine overdoses usually induce a mild to moderate central nervous system depression; deep coma requiring assisted ventilation is rare, and should prompt a search for other toxic substances. The severity of the CNS depression is influenced by the dose, the age of the patient and his or her clinical status prior to the ingestion, and the coingestion of other CNS depressants. In severe overdoses, benzodiazepines can occasionally induce cardiovascular and pulmonary toxicity, but deaths resulting from pure benzodiazepine overdoses are rare.
Quantitative determinations of benzodiazepines are not useful in the clinical management of intoxicated patients since there is no correlation between serum concentrations and pharmacological and toxicological effects.
Benzodiazepine overdoses occurring during pregnancy rarely induce serious morbidity in mothers or fetuses, although large doses administered near delivery can induce respiratory depression in neonates. The teratogenic potential of benzodiazepines remains controversial, but is probably small if it exists at all.
There is clear evidence that the prolonged use of even therapeutic doses of benzodiazepines will lead to dependence. The risk of developing significant withdrawal symptoms is related to dosage and duration of treatment.
Prevention of gastrointestinal absorption should be initiated in all intentional benzodiazepine overdoses. Forced diuresis and dialysis techniques are not indicated since they will not significantly accelerate the elimination of these agents. Intravenous administration of flumazenil, a pure benzodiazepine antagonist, effectively reverses benzodiazepine-induced CNS depression.
Similar content being viewed by others
References
Aarskog D. Association between maternal intake of diazepam and oral clefts. Lancet 2: 921–922, 1975
Abernethy DR, Greenblatt DJ, Divoll M, Arendt R, Ochs HR, et al. Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids. New England Journal of Medicine 306: 791–792, 1982
Abernethy DR, Greenblatt DJ, Divoll M, Moschitto LJ, Harmatz JS, et al. Interaction of cimetidine with the triazolobenzodi-azepines alprazolam and triazolam. Psychopharmacology 80: 275–278, 1983a
Abernethy DR, Greenblatt DJ, Ochs HR, et al. Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives. Clinical Pharmacology and Therapeutics 33: 628–632, 1983b
Acosta D, Chappell R. Cardiotoxicity of diazepam in cultured heart cells. Toxicology 8: 311–317, 1977
Allen CJ, Gough KR. The effect of doxapram on heavy sedation produced by intravenous diazepam in a patient with tetanus. British Medical Journal 286: 1181–1182, 1983
Allen MD, Greenblatt DJ, Lacasse Y, Shader RI. Pharmacokinetic study of lorazepam overdosage. American Journal of Psychiatry 137: 1414–1415, 1980
Allonen G, Ziegler G, Klotz U. Midazolam kinetics. Clinical Pharmacology and Therapeutics 30: 653–661, 1981
Alvan G, Siwers B, Vessman J. Pharmacokinetics of oxazepamin healthy volunteers. Acta Pharmacologica et Toxicologica 40(Suppl. 1): 40–51, 1977
Amrein R, Leishman B, Bentzinger C, Roncari G. Flumazenil in benzodiazepine antagonism: actions and clinical use in intoxications and anesthesiology. Medical Toxicology 2: 411–429, 1987
Ananth J. Side effects in the neonate from psychotropic agents excreted through breast-feeding. American Journal of Psychiatry 135: 801–805, 1978
Andreasen PB, Hendel J, Greisen G, Hvidger EF. Pharmacokinetics of diazepam in disordered liver function. European Journal of Clinical Pharmacology 10: 115–120, 1976
Arendt RM, Greenblatt DJ, de Jong RH, et al. In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action, and peripheral distribution. Journal of Pharmacology and Experimental Therapeutics 227: 95–106, 1983
Ayd Jr FJ. Benzodiazepines: dependence and withdrawal. Journal of the American Medical Association 242: 1401–1402, 1979
Aziz K. Drugs-of-abuse testing: screening and confirmation. Clinics in Laboratory Medicine 10: 493–502, 1990
Baehrendtz S, Hojer J. Flumazenil in self-induced benzodiazepine poisoning. European Journal of Anaesthesiology (Suppl. 2): 287–293, 1988
Bal TS, Johnson B, Kilner EA, Sunter JP, Cowan WK. Three deaths involving triazolam -analytical aspects. Journal of the Forensic Science Society 29: 119–123, 1989
Balter MB, Manheimer DI, Mellinger GD, et al. A cross-nationalcomparison of anti-anxiety/sedative drug use. Current MedicalResearch Opinion 8(Suppl. 4): 5–20, 1984
Bansky G, Meier PJ, Ziegler WH, et al. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1: 1324–1325, 1985
Barry WS, St Clair SM. Exposure to benzodiazepines in utero. Lancet 1: 1436–1437, 1987
Bell EF. The use of naloxone in the treatment of diazepam poisoning. Journal of Pediatrics 87: 803–804, 1975
Berger R, Green G, Melnick A. Cardiac arrest caused by oral diazepam intoxication. Clinical Pediatrics 14: 842–844, 1975
Bergman U, Boethius G, Swartling PG, Isacson D, Smedby B. Teratogenic effects of benzodiazepine use during pregnancy. Journal of Pediatrics 116: 490–491, 1990
Besunder JB, Blumer JL. Neonatal drug withdrawal syndromes.In Koren (Ed.) Maternal-fetal toxicology: a clinicians’ guide, Marcel Dekker Inc., New York, 1990
Bismuth C, Baud FJ, Du Fretay H, Mellerioi F. Antagoniste Ro 15-1788 dans l’intoxication volontaire par benzodiazepines: valeur diagnostique et thérapeutique. Abstract. Réanimation, Soins Intensifs, Médecine d’Urgence 1: 263, 1986
Bodenham A, Brownlie G, Dixon JS, Park GR. Reversal of sedation by prolonged infusion of flumazenil (Anexate, Ro 15-1788). Anaesthesia 43: 376–378, 1988
Bouget J, Breurec JY, Baert A, Yapo-Ette H, Feuillu A, et al. Intérêt du charbon par voie orale chez des patients admis en service d’urgence pour absorption volontaire de benzodiazepines. Journal de Toxicologie Clinique et Expérimentale 9: 287–289, 1989
Boxenbaum HGI, Geitner KA, Jack MK, Dixon WR, Kaplan SA. Pharmacokinetics and biopharmaceutical profile of chlordi-azepoxide HCl in healthy subjects: single dose studies by intravenous, intramuscular and oral routes. Journal of Pharmacokinetics and Biopharmaceutics 5: 3–23, 1977a
Boxenbaum HG, Geitner KA, Jack ML, Dixon WR, Kaplan SA. Pharmacokinetic and biopharmaceutic profile of chlordiaze-poxide HCI in healthy subjects: multiple-dose oral administration. Journal of Pharmacokinetics and Biopharmaceutics 5: 25–39, 1977b
Brouard A, Perdu E, Bismuth C. Monographie systematisée, réalisée à la demande de l’OMS et de la Communauté Européenne, dans le cadre d’une commission de revision des antidotes. Journal de Toxicologie Clinique et Expérimentale 4: 223–237, 1987
Burkhart KK, Kulig KW. The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. Annals of Emergency Medicine 19: 319–321, 1990
Busto U, Kaplan HL, Sellers EM. Benzodiazepine-associated emergencies in Toronto. American Journal of Psychiatry 137: 224–227, 1980
Busto U, Lanctôt KL, Isaac P, Manuella A. Benzodiazepine use and abuse in Canada. Canadian Medical Association Journal 141: 917–921, 1989
Busto U, Sellers EM, Naranjo CA, Cappeli H, Sanchez-Craig M, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315: 854–859, 1986
Carroll WM, Mastiglia FL. Alpha and beta coma in drug intoxication. British Medical Journal 2: 1518–1519, 1977
Castleden CM, George CF, Marcer D, Hallett C. Increased sensitivity to nitrazepam in old age. British Medical Journal 1: 10–12, 1977
Cate JC, Jatlow PI. Chlordiazepoxide overdose: interpretation of serum drug concentrations. Clinical Toxicology 6: 553–561,1973
Cerqueira Ma J, Olle C, Bellart J, Baro F, Cabero L, et al. Intoxicationby benzodiazepines during pregnancy. Lancet 1: 1341,1988
Choux C, Gueugniaud PY, Prost G, Vaudelin T, Bertin-Maghit M, et al. Limites du flumazénil en pratique pré-hospitalière. Presse Médicale 19: 719, 1990
Cimbura G, Lucas DM, Bennett RC, Warren RA, Simpson HM. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. Journal of Forensic Sciences 27: 855–867, 1982
Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. Journal of Clinical Pharmacology 26: 292–298, 1986
Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation and alcohol. British Medical Journal 289: 351–353, 1984
Costa E, Guidotti A, Mao CC. Evidence for the involvement of GABA in the action of benzodiazepines: studies on rat cerebellum. Advances in Biochemical Psychopharmacology 14: 113–130, 1975
Crevoisier C, Eckert M, Heizmann P, Thurneysen DJ, Ziegler WH. Relation entre l’effet clinique et al pharmacocinétique du midazolam après l’administration IV ou IM. Arzneimittel-Forschung 31: 2211–2215, 1981
Curry SH, Smith CM. Diazepam-ethanol interaction in humans: addiction or potentiation? Communications in Psychopharmacology 3: 101–113, 1979
Czeizel A. Diazepam, phenytoin, and etiology of cleft lip and/or cleft palate. Lancet 1: 810, 1976
Darragh A, Lambe R, Kenny M, Brick I, Taffe W, et al. RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam unavailability. British Journal of Clinical Pharmacology 14: 677–682, 1982
Desmond PV, Patwardhan RV, Schenker S, Hoyumpa AM. Short-term ethanol administration impairs the elimination of chlordiazepoxide (Librium) in man. European Journal of Clinical Pharmacology 18: 275–278, 1980a
Desmond PV, Patwardhan RV, Schenker S, Speeg KV. Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Annals of Internal Medicine 93: 266–268, 1980b
Diliberti L, O’Brien ML, Turner T. The use of physostigmine as an antidote in accidental diazepam intoxication. Journal of Pediatrics 86: 106–107, 1975
Divoll M, Greenblatt DJ. Alcohol does not enhance diazepam absorption. Pharmacology 22: 263–268, 1981a
Divoll M, Greenblatt DJ. Plasma concentrations of temazepam, a 3-hydroxy benzodiazepine, determined by electron-capture gas-liquid chromatography. Journal of Chromatography 222: 125–128, 1981b
Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. Journal of Pharmaceutical Sciences 70: 1104–1107, 1981a
Divoll M, Greenblatt DJ, Lacasse Y, Shader RI. Benzodiazepine overdosage: plasma concentrations and clinical outcome. Psychopharmacology 73: 381–383, 1981b
Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesthesia and Analgesia 62; 1–8, 1983
Dorian P, Sellers EM, Kaplan HL, Hamilton C, Greenblatt DJ, et al. Triazolam and ethanol interaction: kinetic and dynamic consequences. Clinical Pharmacology and Therapeutics 37: 558–562, 1985
Eckert M, Ziegler WH, Cano JP, et al. Pharmacokinetics and pharmacodynamics of flurazepam in man: part I. Drugs under Experimental and Clinical Research 9: 77–84, 1983
El-Khordagui LK, Saleh AM, Khalil SA. Adsorption of benzodiazepines on charcoal and its correlation with in vitro and in vivo data. Pharmaceutica Acta Helvetiae 62: 28–32, 1987
Ellinwood EH, Healtherly DG, Nikardo AM, Bjomsson TD, Kilts C. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology 86: 392–399, 1985
Fantozzi R, Caramelli L, Barattini M, et al. Clinical experiences with Ro 15–1788 (Anexate) in benzodiazepine and mixed-drug overdoses. Resuscitation (Suppl. 16): S79-S82, 1988
Farley TA. Severe hypernatremic dehydration after use of an activated charcoal-sorbitol suspension. Journal of Pediatrics 109: 719–722, 1986
Ferslew KE, Hagardorn AN, McCormick WF. Postmortem determination of the biological distribution of sufentanil and midazolam after an acute intoxication. Journal of Forensic Sciences 34: 249–257, 1989
Finkle BS, McCloskey KL, Goodman LS. Diazepam and drug-associated deaths: a survey in the United States and Canada. Journal of the American Medical Association 242: 429–434, 1979
Ford S, Ankier SI, Corless D, et al. Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients. Xenobiotica 8: 1001–1009, 1987
Forster AF, Morel DM, Bachmann M, et al. Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone: a double-blind randomized study. Anesthesia and Analgesia 62: 920–924, 1983
Friedman H, Greenblatt DJ, Burnstein ES, Harvatz JS, Shader RI. Population study of triazolam pharmacokinetics. British Journal of Clinical Pharmacology 22: 639–642, 1986
Fucella LM, Bolcioni G, Tamassia V, Ferrario L, Tognoni G. Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. European Journal of Clinical Pharmacology 12: 383–386, 1977
Garnier R, Medemach C, Harbach S, Fournier E. Agitation et hallucinations lors des intoxications aiguës par le lorazépam chez l’enfant. Annales de Pédiatrie 31: 286–289, 1984
Garriott JC, Latman N. Drug detection in cases of driving under the influence. Journal of Forensic Sciences 21: 398–415, 1976
Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clinical Pharmacokinetics 16: 337–364, 1989
George CF, Robertson D. Clinical consequences of abrupt drug withdrawal. Medical Toxicology 2: 367–382, 1987
Ghoneim MM, Mewaldt SP. Benzodiazepines and human memory: a review. Anesthesiology 72: 926–938, 1990
Goethe JW, Edelman SL. Chlordiazipoxide toxicity in Limbitrol overdose. American Journal of Psychiatry 142: 774, 1985
Greenblatt DJ, Abernethy DR, Divoll M, Harmatz JS, Shader RI. Pharmacokinetic properties of benzodiazepine hypnotics. Journal of Clinical Psychopharmacology 3: 129–132, 1983a
Greenblatt DJ, Abernethy DR, Locniskar A, Ochs HR, Harmatz JS, et al. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition. Clinical Pharmacology and Therapeutics 38: 697–703, 1985
Greenblatt DJ, Allen MD, Locniskar A, Harmatz JS, Shader RI. Lorazepam kinetics in the elderly. Clinical Pharmacology and Therapeutics 26: 103–113, 1979
Greenblatt DJ, Allen MD, Noel BJ, Shader RI. Acute overdosage with benzodiazepine derivatives. Clinical Pharmacology and Therapeutics 21: 497–514, 1977a
Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, et al. Alprazolam kinetics in the elderly. Archives of General Psychiatry 40: 287–290, 1983c
Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, et al. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. British Journal of Clinical Pharmacology 15: 303–309, 1983d
Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI. Diazepam disposition determinants. Clinical Pharmacology and Therapeutics 27: 301–312, 1980a
Greenblatt DJ, Divoll M, Harmatz JS. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. Journal of Pharmaceutical Sciences 71: 248–252, 1982
Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Oxazepam kinetics: effects of age and sex. Journal of Pharmacology and Experimental Therapeutics 215: 86–91, 1980b
Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, et al. Clobazam kinetics in the elderly. British Journal of Clinical Pharmacology 12: 631–636, 1981
Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, et al. Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation. Clinical Pharmacokinetics 8: 83–94, 1983b
Greenblatt DJ, Ehrenberg BL, Gunderman J, et al. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clinical Pharmacology and Therapeutics 45: 356–365, 1989
Greenblatt DJ, Schillings RT, Kyriakopoulos AA, et al. Clinical pharmacokinetics of lorazepam: I. Absorption and disposition of oral 14C-Lorazepam. Clinical Pharmacology and Therapeutics 20: 329–341, 1976
Greenblatt DJ, Shader RI. Prazepam and lorazepam, two new benzodiazepines. New England Journal of Medicine 299: 1342–1344, 1978
Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Kosch-Weser J. Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. American Journal of Psychiatry 134: 559–562, 1977b
Greenblatt DJ, Shader RI, Macleod SM, Sellers EM. Flurazepam hydrochloride. Clinical Pharmacology and Therapeutics 17: 1–14, 1975
Greenblatt DJ, Shader RI, Weinberger DR, Allen MD, Mac-Laughlin DS. Effect of cocktail on diazepam absorption. Psychopharmacology 57: 199–203, 1978b
Greenblatt DJ, Woo E, Divoll M, Allen M, Orsulak PJ, et al. Rapid recovery from massive diazepam overdose. Journal of the American Medical Association 240: 1872–1874, 1978a
Haefely WE. Pharmacology of the benzodiazepine receptor. European Archives of Psychiatry and Neurological Sciences 238: 294–301, 1989
Haefely W, Kulcsar A, Möhler H, et al. Possible involvement of GABA in the central actions of benzodiazepines. Advances in Biochemical Psychopharmacology 14: 131–151, 1975
Harrison M, Busto U, Naranjo CA, Kaplan HL, Sellers EM. Diazepam tapering in detoxification for high-dose benzodiazepine abuse. Clinical Pharmacology and Therapeutics 36: 527–533, 1984
Hayes SL, Pablo G, Radomski T, Palmer RF. Ethanol and oral diazepam absorption. New England Journal of Medicine 296: 186–189,1977
Heizmann P, Eckert M, Zeigler WH. Pharmacokinetics and bioavailability of midazolam in man. British Journal of Clinical Pharmacology 16: 43S–49S, 1983
Heyndrickx B. Fatal intoxication due to flunitrazepam. Journal of Analytical Toxicology 11: 278, 1987
Higgitt AC, Lader MH, Fogany P. Clinical management of benzodiazepine dependence. British Medical Journal 291: 688–691, 1985
Hiss J, Hepler BR, Falkowski AJ, Sunshine I. Fatal bradycardia after intentional overdose of cimetidine and diazepam. Lancet 2: 982, 1982
Hofer P, Scollo-Lavizzari G. Benzodiazepine antagonist Ro 15-1788 in self-poisoning: diagnostic and therapeutic use. Archives of Internal Medicine 145: 663–664, 1985
Höjer J, Baehrendtz S. The effect of flumazenil (Ro 15-1788) in the management of self-induced benzodiazepine poisoning. Acta Medica Scandinavica 224: 357–365, 1988
Höjer J, Baehrendtz S, Gustafsson L. Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period. Journal of Internal Medicine 226: 117–122, 1989
Højgaard AD, Andersen PT, Møller-Petersen J. Rhabdomyolisis and acute renal failure following an overdose of doxepin and nitrazepam. Acta Medica Scandinavica 223: 79–82, 1988
Hoyumpa A, Patwardhan R, Maples M, Desmond P, Johnson R, et al. Effect of short-term ethanol administration on lorazepa mmetabolism. Gastroenterology 79: 1027, 1980
Hughes FW, Forney RB, Richards AB. Comparative effect in human subjects of chlordiazepoxide, diazepam, and placebo on mental and physical performance. Clinical Pharmacology and Therapeutics 6: 139–145, 1965
Hunkeler W, Mönier H, Pieri L, et al. Selective antagonists of benzodiazepines. Nature 290: 514–516, 1981
Jatlow P, Dobular K, Bailey D. Serum diazepam concentrations in overdose: their significance. American Journal of Clinical Pathology 72: 571–577, 1979
Jeffrey DI, Withfield MF. Lorazepam poisoning. British Medical Journal 4: 719, 1974
Jochemsen R, Van Der Graaff, Boeijinga JK, Breimer DD. Influence of sex, menstrual cycle, and oral contraception on the disposition of nitrazepam. British Journal of Clinical Pharmacology 13: 319–324, 1982
Jochemsen R, Van Rijn PA, Hazelet TGM, Van Boxtel CJ, Breimer DD. Comparative pharmacokinetics of midazolam and loprazolam in healthy subjects after oral administration. Biopharmaceutics and Drug Disposition 7: 53–61, 1986
Jochemsen R, Wesselman JGJ, Van Boxtel CJ, Hermans J, Breimer DD. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects. British Journal of Clinical Pharmacology 16 (Suppl. 2): 291S–298S, 1983
Jones DJ, Stehling LC, Zauder HL. Cardiovascular responses to diazepam and midazolam maleate in the dog. Anesthesiology 51: 430–434, 1979
Jordan C, Lehaue JR, Jones JG. Respiratory depression following diazepam: reversal with high dose naloxone. Anesthesiology 53: 293–298, 1980
Kangas L, Breimer DD. Clinical pharmacokinetics of nitrazepam. Clinical Pharmacokinetics 6: 346–366, 1981
Kanto JH. Use of benzodiazepines during pregnancy, labour, and lactation, with particular reference to pharmacokinetic consideration. Drugs 23: 354–380, 1982
Kaplan SA, Jack ML, Alexander K, Weinfeld RE. Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. Journal of Pharmaceutical Sciences 62: 1789–1796, 1973
Kelly RC, Krent L, Sunshine I. Association of benzodiazepines with death in a major metropolitan area. Journal of Analytical Toxicology 6: 91–96, 1982
King LA. Synergistic effect of benzodiazepines in fatal amitriptyline poisonings. Lancet 2: 982–983, 1982
Klotz U, Antonin KH, Bieck PR. Comparison of the kinetics of diazepam after single and subchronic doses. European Journal of Clinical Pharmacology 10: 121–126, 1976
Klotz U, Duka T, Dorow R, Doenicke A. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788. British Journal of Clinical Pharmacology 19: 95–98, 1985b
Klotz U, Reimann I. Delayed clearance of diazepam due to cimetidine. New England Journal of Medicine 302: 1012–1014, 1980
Klotz U, Ziegler G, Ludwig L, Reimann IW. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans. Journal of Clinical Pharmacology 25: 400–406, 1985a
Klotz U, Ziegler G, Reimann IW. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. European Journal of Clinical Pharmacology 24: 115–117, 1984
Klotz U, Ziegler G, Rosenkranz B, Mikus G. Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol? British Journal of Clinical Pharmacology 22: 513–520, 1986
Knudsen L, Lonka L, Sorensen BH, Kirkegaard L, Jensen OV, et al. Benzodiazepine intoxication treated with flumazenil (Anexate, Ro 15-1788). Anaesthesia 43: 274–276, 1988
Kraus JW, Desmond PV, Marshall JP, Johnson RF, Schenker S, et al. Effect of aging and liver disease on disposition of lorazepam. Clinical Pharmacology and Therapeutics 24: 411–419, 1978
Krieger J, Perianu M, Bertagna C, Manfen P, Kurtz D. Hypnotic benzodiazepines: relationship between sleep parameters and pharmacokinetics of loprazolam. Drug Development and Research 3: 143–152, 1983
Kumar A, Mohan M, Anand NK. Aminophylline in neonatal diazepam intoxication. Indian Pediatrics 24: 602–604, 1987
Laegreid I, Olegard R, Conradi N, Hagberg G, Wahlström J, et al. Congenital malformations and maternal consumption of benzodiazepines: a case-control study. Developmental Medicine and Child Neurology 32: 432–441, 1990
Laegreid L, Olegard R, Wahlström J, Conradi N. Abnormalities in children exposed to benzodiazepines in utero. Lancet 1: 108–109, 1987
Laegreid L, Olegard R, Wahlström J, Conradi N. Teratogenic effects of benzodiazepine use during pregnancy. Journal of Pediatrics 114: 126–131, 1989
Leykin Y, Halpern P, Silbiger A, et al. Acute poisoning treated in the intensive care unit: a case series. Israel Journal of Medical Sciences 25: 98–102, 1989
Lheureux P, Askenasi R. Treatment of benzodiazepine overdose with Ro 15-1788. Archives of Internal Medicine 146: 1241,1986
Lheureux P, Askenasi R. Specific treatment of benzodiazepine overdose. Human Toxicology 7: 165–170, 1988
Lheureux P, Askenasi R. Agonism and antagonism at the benzodiazepine-receptor: a new concept for new approach of common drug poisoning. Acta Anaesthesiologica Belgica 40: 23–28, 1989
Linnoila M, Hakkinen S. Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving. Clinical Pharmacology and Therapeutics 15: 368–373, 1974
Linnoila M, Mattila MJ. Drug interaction on psychomotor skills related to driving: diazepam and alcohol. European Journal of Clinical Pharmacology 5: 186–194, 1973a
Linnoila M, Mattila MJ. Proceedings: drug interaction on driving skills as evaluated by laboratory tests and by driving simulator. Pharmakopsychiatrie, Neuro-Psychopharmakologie 6: 127–132, 1973b
Litovitz T. Fatal benzodiazepine toxicity? American Journal of Emergency Medicine 5: 472–473, 1987
Litovitz TL, Martin TG, Schmitz B. 1986 Annual report of the American association of poison control centers national data collection system. American Journal of Emergency Medicine 5: 405–445, 1987
Litovitz TL, Schmitz BF, Holm KC. 1988 Annual report of the American Association of Poison Control Centers national data collection system. American Journal of Emergency Medicine 7: 495–545, 1989
Litovitz TL, Schmitz BF, Matyunas N, Martin TG. 1987 Annual report of the American Association of Poison Control Centers national data collection system. American Journal of EmergencyMedicine 6: 479–515, 1988
Lundberg GD, White JM, Hoffman KI. Drugs (other than or in addition to ethyl alcohol) and driving behavior a collaborative study of the California Association of Toxicologists. Journal of Forensic Sciences 24: 207–215, 1979
MacLeod SM, Sellers EM, Giles HG, et al. Interaction of disulfiram with benzodiazepines. Clinical Pharmacology and Therapeutics 24: 583–589, 1978
Mandelli M, Tognoni G, Garattini S. Clinical pharmacokinetics of diazepam. Clinical Pharmacokinetics 3: 72–91, 1978
Marks J. Techniques of benzodiazepine withdrawal in clinical practice: a consensus workshop report. Medical Toxicology 3: 324–333, 1988
Martin CD, Chan SC. Distribution of temazepam in body fluids and tissues in lethal overdose. Journal of Analytical Toxicology 10: 77–78, 1986
Massault J, d’Hollander A, Barvais L, Dubois-Primo J. Haemodynamic effects of midazolam in anaesthetized patients with coronary artery disease. Acta Anaesthesiologica Scandinavica 27: 299–302, 1983
McCormick SR, Nielsen J, Jatlow PI. Alprazolam overdose: clinical findings and serum concentrations in two cases. Journal of Clinical Psychiatry 46: 247–248, 1985
Mennini T, Cotecchia S, Caccia S, Garattini S. Benzodiazepines: relationship between pharmacological activity in the rat and in vivo receptor binding. Pharmacology, Biochemistry and Behavior 16: 529–532, 1982
Mignée C, Garnier R, Conso F, Efthymiou ML, Fournier E. Intoxication aiguë par le flunitrazépam. Thérapie 35: 581–589, 1980
Möhler H, Okada T. Benzodiazepines receptors: demonstration in the central nervous system. Science 198: 849–851, 1977
Möhler H, Burkard WP, Keller HH, Richards JG, Haefely W. Benzodiazepine antagonist RO 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. Journal of Neurochemistry 37: 714–722, 1981
Möhler H, Richards JG. Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature 294: 763–765, 1981
Morland J, Setekleiv J, Haffher JFW, et al. Combined effects of diazepam and ethanol on mental and psychomotor functions. Acta Pharmacologica et Toxicologica 34: 5–15, 1974
Nagy J, Decsi L. Physostigmine, a highly potent antidote for acute experimental diazepam intoxication. Neuropharmacology 17: 469–475, 1978
Norman TR, Burrows GD. Plasma concentrations of benzodiazepines: a review of clinical findings and implications. Progress in Neuropsychopharmacology and Biological Psychiatry 8: 115–126, 1984
O’Boyle C, Lambe R, Darragh A, Taffe W, Brick I, et al. RO 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability. British Journal of Anaesthesiology 55: 349–356, 1983
Ochs HR, Greenblatt DJ, Gugler R, Muntefering G, Locniskar A, et al. Cimetidine impairs nitrazepam clearance. Clinical Pharmacology and Therapeutics 34: 227–230, 1983
Ochs HR, Greenblatt DJ, Roberts GM, Dengler HJ. Diazepam interaction with antituberculosis drugs. Clinical Pharmacology and Therapeutics 29: 671–678, 1981
Oliver JS, Smith H. Determination of nitrazepam in poisoning cases. Forensic Science 4: 183–186, 1974
Olson KR, Yin L, Osterloh J, Tani A. Coma caused by trivial triazolam overdose. American Journal of Emergency Medicine 3: 210–211, 1985
Oreland L. The benzodiazepines: a pharmacological overview. Acta Anaesthesiologica Scandinavica 32 (Suppl. 88): 13–16, 1987
O’Sullivan GF, Wade DN. Flumazenil in the management of acute drug overdosage with benzodiazepines and other agents. Clinical Pharmacology and Therapeutics 42: 254–259, 1987
Owen RT, Tyrer P. Benzodiazepine dependence: a review of the evidence. Drugs 25: 385–398, 1983
Pacifici GM, Placidi GF, Fornaro P, Gomeni R. Pinazepam: a precursor of N-desmethyldiazepam. European Journal of Clinical Pharmacology 22: 225–228, 1982
Patwardhan RV, Yarborough GW, Desmond PV, Johnson RF, Schenker S, et al. Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology 79: 912–916, 1980
Peel HW, Perrigo BT, Mikhael NZ. Detection of drugs in saliva of impaired drivers. Journal of Forensic Sciences 29: 185–189, 1984
Perry PJ, Wilding DC, Fowler RC, et al. Absorption of oral and intramuscular chlordiazepoxide by alcoholics. Clinical Pharmacology and Therapeutics 23: 535–541, 1978
Petursson H, Lader MH. Withdrawal from long term benzodiazepine treatment. British Medical Journal 283: 643–645, 1981
Pevnick JS, Jasinski DR, Haertzen CA. Abrupt withdrawal from therapeutically administered diazepam. Archives of General Psychiatry 35: 995–998, 1978
Pond SM, Phillips M, Benovitz NL, et al. Diazepam kinetics in acute alcohol withdrawal. Clinical Pharmacology and Therapeutics 25: 832–836, 1979
Polc P, Bonetti EP, Schaffner R, Haefely WE. A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines and phenobarbitone. Naunyn-Schmiedeberg’s Archives of Pharmacology 321: 260–264, 1982
Rada RT, Kellner R, Buchanan JG. Chlordiazepoxide and alcohol: a fatal overdose. Journal of Forensic Sciences 20: 544–547, 1974
Reidenberg MM, Levy M, Warner H, et al. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clinical Pharmacology and Therapeutics 23: 371–374, 1978
Rementeria JL, Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. Pediatric Pharmacology 90: 123–126, 1977
Richman S, Harris RD. Acute pulmonary edema associated with librium abuse. Radiology 103: 57–58, 1972
Ritz R, Zuber M, Elasser S, Scollo-Lavizzari G. Use of flumazenil in intoxicated patients with coma: a double-blind placebo-controlled study in ICU. Intensive Care Medicine 16: 242–247, 1990
Roberts RK, Wilkinson GR, Branch RA, Schenker S. Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium). Gastroenterology 75: 479–485, 1978
Roncari G, Ziegler WH, Guentert TW. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. British Journal of Clinical Pharmacology 22: 421–428, 1986
Rosenberg L, Mitchell AA, Parsell JL, Pashayan H, Louik C, et al. Lack of relation of oral clefts to diazepam use during pregnancy. New England Journal of Medicine 309: 1282–1285, 1983
Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart disease. American Journal of Epidemiology 109: 433–439, 1979
Ruff RL, Kutt H, Hafler D. Prolonged benzodiazepine coma. New York State Journal of Medicine 81: 776–777, 1981
Rupp W, Badian M, Christ O, Hajdú P, Kulkarni RD, et al. Pharmacokinetics of single and multiple doses of clobazam in humans. British Journal of Clinical Pharmacology 7: 51S–57S, 1979
Safra MJ, Oakley GP. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2: 478–480, 1975
Saxen I. Associations between oral clefts and drugs taken during pregnancy. International Journal of Epidemiology 4: 37–44, 1975
Scavone JM, Greenblatt DJ, Friedman H, Shader RI. Enhanced bioavailability of triazolam following sublingual versus oral administration. Clinical Pharmacology 26: 208–210, 1986
Scavone JM, Greenblatt DJ, Shader DJ. Alprazolam kinetics following sublingual and oral administration. Journal of Clinical Psychopharmacology 7: 332–334, 1987
Schneiderman JF. Nonmedical drug and chemical use in pregnancy. In Koren (Ed.) Maternal-fetal toxicology: a clinicians’ guide, Marcel Dekker, Inc., New York, 1990
Schwartz MA, Koechlin BA, Postma E, Palmer S, Krol G. Metabolism of diazepam in cat, dog and man. Journal of Pharmacology and Experimental Therapeutics 149: 423–435, 1965
Scollo-Lavizzari G. First clinical investigation of the benzodiazepine antagonist Ro 15-1788 in comatose patients. European Neurology 22: 7–11, 1983
Scollo-Lavizzari G, Matthis H. Benzodiazepine antagonist Ro 15-1788 in ethanol intoxication: a pilot study. European Neurology 24: 352–354, 1985
Sellers EM, Busto U. Benzodiazepines and ethanol: assessment of the effects and consequences of psychotropic drug interaction. Journal of Psychopharmacology 2: 249–262, 1982
Sellers EM, Giles GH, Greenblatt DJ, Naranjo CA. Differential effects on benzodiazepine disposition by disulfiram and ethanol. Arzneimittel-Forschung 30: 882–886, 1980b
Sellers EM, Greenblatt DJ, Giles HG, et al. Chlordiazepoxide and oxazepam disposition in cirrhosis. Clinical Pharmacology and Therapeutics 26: 240–246, 1979
Sellers EM, Greenblatt DJ, Zilm DH, Degani N. Decline in chlordiazepxoside plasma levels during fixed-dose therapy of alcohol withdrawal. British Journal of Clinical Pharmacology 6: 370–372, 1978
Sellers EM, Naranjo CA, Giles HG, et al. Mechanism of ethanoldiazepam pharmacokinetic interactions. Clinical Pharmacology and Therapeutics 27: 286, 1980a
Sellman R, Pekkarinen A, Kangas L, et al. Reduced concentrations of plasma diazepam in chronic alcoholic patients following an oral administration of diazepam. Acta Pharmacologica et Toxicologica 36: 25–32, 1975
Sellman R, Kanto J, Raijola E, et al. Human and animal study on elimination from plasma and metabolism of diazepam after chronic alcohol intake. Acta Pharmacologica et Toxicologica 36: 33–38, 1975b
Shader RI, Georgotas A, Greenblatt DJ, Harmatz JS, Allen MD. Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminium hydroxide. Clinical Pharmacology and Therapeutics 24: 308–315, 1978
Shader RI, Greenblatt DJ, Ciraulo DA, Divoll M, Harmatz JS, et al. Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate. Psychopharmacology 75: 193–197, 1981
Shader RI, Greenblatt DJ, Salzman C, Kochansky G, Harmatz JS. Benzodiazepines: safety and toxicity. Diseases of the Nervous System 5: 23–26, 1975
Shiono PH, Mills JL. Oral clefts and diazepam use during pregnancy. New England Journal of Medicine 311: 919–920, 1984
Skerrit JH, Johnston GAR. Enhancement of GABA binding by benzodiazepines and related anxiolytics. European Journal of Pharmacology 89: 193–198, 1983
Smith MT, Eadie MJ, O’Rourke Brophy T. The pharmacokinetics of midazolam in man. European Journal of Clinical Pharmacology 19: 271–278, 1981
Smith RB, Divoll M, Gillespie WR, Greenblatt DJ. Effect of subject age and gender on the pharmacokinetics ofr oral triazolam and temazepam. Journal of Clinical Psychopharmacology 3: 172–176, 1983
Smith RB, Heazlewood V, Eadie MJ, O’Rourke Brophy T, Tyrer JH. Pharmacokinetics of midazolam in the aged. European Journal of Clinical Pharmacology 26: 381–388, 1984a
Smith RB, Kroboth PD, Phillips JP. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration. Journal of Clinical Pharmacology 26: 120–124, 1986
Smith RB, Kroboth PD, Vanderlugt JT, Phillips JP, Juhl RP. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Psychopharmacology 84: 452–456, 1984b
Squires RF, Braestrup C. Benzodiazepine receptors in rat brain. Nature 266: 732–734, 1977
Stevens LA, Bevan CD, Salmon J, Krieger J, Perianu M, et al. Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers. European Journal of Clinical Pharmacology 25: 651–655, 1983
Stevens LA, Pidgen AW, Bevan CD, Igns RMJ, Lawrence JR, et al. Correlation of the clinical pharmacodynamics of loprazolam with serum concentrations. Xenobiotica 15: 623–631, 1985
Stirt JA. Aminophylline is a diazepam antagonist. Anesthesia and Analgesia 60: 767–768, 1981
Stringer MD. Adult respiratory distress syndrome associated with flurazepam overdose. Journal of the Royal Society of Medicine 78: 74–75, 1985
Sury MRJ, Billingham I, Russell GN, et al. Acute benzodiazepine withdrawal syndrome after midazolam infusions in children. Critical Care Medicine 17: 301–302, 1989
Taeuber K, Badian M, Brettel HF, et al. Kinetic and dynamic interaction of clobazam and alcohol. British Journal of Clinical Pharmacology 7: 91S–97S, 1979
Tedeschi G, Riva R, Baruzzi A. Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients. British Journal of Clinical Pharmacology 11: 619–622, 1981
Thearle MJ, Dunn PM, Hailey DM. Exchange transfusion for diazepam intoxication at birth followed by jejunal stenosis. Proceedings of the Royal Society of Medicine 66: 13–14, 1973
Thiessen JJ, Sellers EM, Denbeigh P, Dolman L. Plasma protein binding of diazepam and tolbutamine in chronic alcoholics. Journal of Clinical Pharmacology 16: 345–351, 1976
Torry JM. A case of suicide with nitrazepam and alcohol. Practioner 217: 648–649, 1976
Trappler B, Bezeredi T. Triazolam intoxication. Canadian Medical Association Journal 126: 893–894, 1982
Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1: 520–523, 1981
Van der Kleijn E, Van Rossum JM, Muskens ETJ, Rijntjes NVM. Pharmacokinetics of diazepam in dogs, mice, and humans. Acta Pharmacologica et Toxicologica 29: 109–129, 1971
Vissuzaine C, Coste F, Bocquet L. Rhabdomyolyse cardiaque et squelettique au cours d’un coma par intoxication médicamenteus. Coeur et Médecine Interne 15: 615–623, 1976
Voltz M, Christ O, Kellner HM, et al. Kinetics and metabolism of clobazam in animals and man. British Journal of Clinical Pharmacology 7: 41S–50S, 1979
von Staak M, Moosmayer A. Pharmacokinetic studies on interactions between dipotassium chlorazepate and alcohol after oral administration. Arzneimittel-Forschung 28: 1187–1191, 1978
Welch TR, Rumack BH, Hammond K. Clonazepam overdose resulting in cyclic coma. Clinical Toxicology 10: 433–436, 1977
White JM, Clardy DO, Graves MH, et al. Testing for sedative-hypnotic drugs in the imparied driver: a survey of 72 000 arrests. Clinical Toxicology 18: 945–957, 1981
Whitelaw AGL, Cummings AJ, McFadyen IR. Effect of maternal lorazepam on the neonate. British Medical Journal 282: 1106–1108, 1981
Whiting B, Lawrence JR, Skellern GG, et al. Effects of acute alcohol intoxication on the metabolism and plasma kinetics of chlordiazepoxide. British Journal of Clinical Pharmacology 7: 95–100, 1979
Winokur A, Rickets K, Greenblatt DJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long term low dosage administration of diazepam: a double blind placebo controlled case study. Archives of General Psychiatry 37: 101–105, 1980
Winter RM, Czeizel A, Lendvay A, Gerhardsson M, Alfredsson L. In-utero exposure to benzodiazepines. Lancet 1: 627–628, 1987
Ziegler G, Ludwig L, Klotz U. Relationships between plasma levels and psychological effects of benzodiazepines. Pharmacopsychiatry 16: 71–76, 1983
Zileli MS, Telatar F, Deniz S, Ilter E, Adalar N. Pseudohyperosmolar nonketoacidotic coma due to oxazepam intoxication. Clinical Toxicology 5: 337–341, 1972
Zuber M, Elasser S, Ritz R, Scollo-Lavirazzi G. Flumazenil (Anexate®) in severe intoxication with carbamazepine (Tegretol®). European Neurology 28: 161–163, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaudreault, P., Guay, J., Thivierge, R.L. et al. Benzodiazepine Poisoning. Drug-Safety 6, 247–265 (1991). https://doi.org/10.2165/00002018-199106040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199106040-00003